December 4, 2019

Khiron Welcomes Legalization of Medical Cannabis in Brazil

Khiron Life Sciences Corp. welcomes today's announcement from ANVISA, the National Agency for Health Surveillance of Brazil.
December 2, 2019

Isracann CEO: Israeli Cultivation Facility Provides Access to European Markets

Isracann CEO Darryl Jones discusses company progress in the Israeli cannabis market.
November 29, 2019

Khiron Announces Chairman Transition and Appointment of Audit Committee Chair

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF, Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in...
November 26, 2019

Khiron Reports Q3 Fiscal 2019 Financial Results, With $47.9 Million Cash Balance and $2.8 Million in Quarterly Revenue

Khiron Life Sciences Corp. (TSXV:KHRN, OTCQB:KHRNF) announced today its financial results for the third quarter ended September 30, 2019.
November 25, 2019

Khiron Receives First Colombian Authorization to Commercialize High-THC Cannabis for Domestic and Export Sales

Khiron announced that it has become the first cannabis company authorized to commercialize high-THC cannabis for both domestic and export...
November 21, 2019

Khiron Director and 55th President of Mexico, Vicente Fox to Present Keynote at UK Cannabis Investor Conference

Khiron Life Sciences Corp. announced that Vicente Fox, will present a keynote address at the Bryan, Garnier & Co Cannabis Conference.
November 19, 2019

Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe’s Largest Medical Cannabis Study with 20,000 Patients

Khiron Life Sciences announced that it will be the exclusive Latin American provider of cannabis medicines to Project Twenty21 in...